CACI: Director Sloane granted 338 RSUs; 2026 vesting dates

CACI International Inc. (CACI) director Stanton D. Sloane reported an equity award on a Form 4.

Rhea-AI Filing Summary

CACI International Inc. (CACI) director Stanton D. Sloane reported an equity award on a Form 4. On October 16, 2025, he acquired 338 Restricted Stock Units (RSUs), listed as derivative securities tied to CACI common stock.

The RSUs vest in four installments during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following this grant, the filing shows 338 derivative securities beneficially owned, held directly.

This is a routine director compensation grant disclosed under Section 16, with a defined vesting schedule that spreads delivery over the 2026 calendar year.

Insider Trade Summary

Grant/Award: 338 shares

Grant/Award 1 txn

Insider Sloane Stanton D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	338	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 338 contracts (Direct)

Footnotes (1)

1. F1. On October 16, 2025, Mr. Sloane was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CACI (CACI) disclose in this Form 4?

A director, Stanton D. Sloane, reported receiving 338 RSUs on October 16, 2025.

How do the 338 CACI RSUs vest for Stanton D. Sloane?

They vest in 2026: 84 on Jan 14, 84 on Apr 14, 85 on Jul 13, and 85 on Oct 11.

What type of security was reported in the CACI Form 4?

Restricted Stock Units (RSUs) listed as derivative securities linked to CACI common stock.

How many derivative securities are shown as beneficially owned after the transaction?

The filing shows 338 derivative securities beneficially owned, held directly.

Who is the reporting person in this CACI Form 4?

Director Stanton D. Sloane.

Is this Form 4 related to an open-market purchase or sale?

No. It reports an RSU grant with a stated vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/20/2025 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sloane Stanton D

(Last) (First) (Middle)

12021 SUNSET HILLS ROAD

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CACI INTERNATIONAL INC /DE/ [ CACI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	10/16/2025		A		338		(1)	(1)	CACI Common Stock	338	(1)	338	D

Explanation of Responses:

1. On October 16, 2025, Mr. Sloane was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.

Remarks:

	Stanton D. Sloane	10/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.